An Exhaustive Monograph on Ibuprofen: From Orthography to Pharmacology and Clinical Application

I. Ibuprofen: Nomenclature, Pronunciation, and Chemical Origins

The foundation of understanding any pharmaceutical agent begins with its name.

The correct spelling of the medication at the center of this analysis is I-B-U-P-R-O-F-E-N.¹

While the spelling is standardized, its pronunciation can vary slightly across different regions and authorities.

The United States National Cancer Institute provides a phonetic guide of

(I-byoo-PROH-fen) ², while MedlinePlus, a service of the National Library of Medicine, offers a similar rendering of

(eye byoo’ proe fen).⁴

Other lexicographical sources provide phonetic transcriptions such as

[ahy-byoo-proh-fuhn, ahy-byoo-proh-fen] and the International Phonetic Alphabet (IPA) notation /aɪˈbjuːprəʊfən/.⁵

These variations are minor and mutually intelligible, but their documentation underscores the importance of precise communication in medical contexts.

The name “ibuprofen” is not a marketing invention but a direct reflection of its molecular identity, a practice common in the mid-20th century when the drug was developed.

This era of pharmaceutical nomenclature often sought to create names that were both memorable and scientifically descriptive.

The name is a portmanteau, a linguistic blend of components from its formal chemical name: isobutylpropionic acid + phenyl group.⁵

This contraction, rearrangement, and respelling of its chemical structure—specifically, isobutylphenylpropionic acid—embeds the drug’s organic chemistry directly into its common name.

The full chemical formula for ibuprofen is C13​H18​O2​.⁵

This formula represents a white, powdered substance used as an anti-inflammatory, analgesic (pain-relieving), and antipyretic (fever-reducing) agent.⁵

The name itself was first recorded in the period of 1965–1970, which aligns perfectly with the timeline of its development and initial launch onto the market.⁵

Therefore, understanding the spelling and etymology of “ibuprofen” is the first step in demystifying the drug.

The name is not merely a label but a piece of data, a historical and chemical signifier that points directly to its scientific origins and its function as a specific type of molecule designed to interact with the body’s chemistry.

II. The Pharmacological Identity: A Nonsteroidal Anti-Inflammatory Drug (NSAID)

Ibuprofen belongs to a large and critically important class of medications known as nonsteroidal anti-inflammatory drugs, or NSAIDs.⁶

This classification is fundamental to understanding its therapeutic effects, its limitations, and its potential for harm.

The NSAID class includes many other widely used medications, such as aspirin, naproxen sodium (commonly sold as Aleve), and a range of prescription-strength drugs like diclofenac and celecoxib.⁷

The term “nonsteroidal” is a key descriptor, as it distinguishes these drugs from corticosteroids (e.g., prednisone), which are another powerful class of anti-inflammatory agents.

NSAIDs were developed to provide anti-inflammatory benefits without the significant side effects associated with long-term steroid use.⁷

The therapeutic actions of ibuprofen—and indeed all NSAIDs—are rooted in a single, elegant mechanism: the inhibition of the body’s production of chemicals called prostaglandins.⁴

Prostaglandins are hormone-like lipid compounds that play a central role in the body’s response to illness and injury.

They are key mediators of the inflammatory cascade, responsible for signaling pain to the brain, elevating body temperature to cause fever, and creating the swelling and redness associated with inflammation.¹

Ibuprofen works by blocking the activity of an enzyme called cyclooxygenase, or COX.⁹

The COX enzyme is the catalyst that synthesizes prostaglandins from fatty acids in cells throughout the body.

By inhibiting the COX enzyme, ibuprofen effectively shuts down the production line for these inflammatory messengers, thereby alleviating the symptoms they cause.⁷

However, this mechanism is a double-edged sword and is central to the entire risk-benefit profile of ibuprofen.

The drug’s action is non-selective, meaning it does not distinguish between the different roles that prostaglandins play in the body.

While some prostaglandins mediate pain and inflammation (the “bad” effects from a patient’s perspective), others perform vital, protective functions (the “good” effects).

For instance, certain prostaglandins are crucial for maintaining the protective mucus lining of the stomach and intestines, guarding against damage from stomach acid.

Other prostaglandins play a key role in regulating blood flow to the kidneys, ensuring they function properly.

Because ibuprofen blocks prostaglandin production systemically, it cannot separate its desired therapeutic effects from its undesired adverse effects.

The very same mechanism that reduces arthritic pain is also what can lead to gastrointestinal bleeding or kidney damage.

This inherent trade-off is the single most important concept for understanding why ibuprofen, despite its effectiveness, carries significant health warnings.

It is not a flaw in the drug, but rather an intrinsic consequence of how it works at a molecular level.

It is also noted that within the NSAID class, ibuprofen is considered a weaker anti-inflammatory agent than some of its counterparts, a nuance that contributes to its specific place in clinical practice and its particular balance of efficacy and risk.⁹

III. Clinical Applications: The Therapeutic Spectrum of Ibuprofen

The efficacy of ibuprofen in reducing pain, fever, and inflammation makes it one of the most versatile medications available for a wide range of conditions.

Its clinical applications span from the management of minor, acute ailments to the long-term symptomatic control of chronic diseases.⁶

3.1 Management of Pain (Analgesic Properties)

As an analgesic, ibuprofen is indicated for the relief of mild to moderate pain.⁹

Its use is well-established for a broad spectrum of common pains.

These include:

• Headaches and Migraines: It is a first-line treatment for tension headaches and can provide relief for migraine pain.⁴
• Musculoskeletal Pain: This category covers general muscle aches, back pain, and pain resulting from sprains and strains.³
• Dental Pain: Ibuprofen is frequently recommended for toothaches and pain following dental procedures.³
• Post-Surgical Pain: It can be used to manage pain after minor surgical interventions.⁹
• Systemic Pain: It is also effective for pain associated with the common cold and flu.⁴
• Other Specific Pains: Its use extends to relieving pain from kidney stones.⁹

3.2 Reduction of Fever (Antipyretic Properties)

In its role as an antipyretic, ibuprofen is widely used to reduce fever in both adults and children.²

This includes fever from various infections as well as post-vaccination fever, a common and expected reaction to immunizations.⁹

3.3 Control of Inflammation and Arthritic Conditions

The anti-inflammatory properties of ibuprofen are fundamental to its use in treating conditions characterized by swelling, redness, and stiffness.¹

It is a cornerstone therapy for a variety of inflammatory and rheumatoid disorders.⁶

• Osteoarthritis and Rheumatoid Arthritis: Ibuprofen is prescribed to relieve the pain, tenderness, swelling, and stiffness caused by these chronic arthritic conditions.⁴ It is critical to recognize that while ibuprofen effectively manages these symptoms, it does not cure the underlying arthritis or halt its progression.¹⁰
• Other Inflammatory Conditions: Its use also includes the treatment of tendonitis, bursitis, and gout.⁷

3.4 Specialized Applications

Beyond these common uses, ibuprofen is employed in more specific clinical scenarios:

• Dysmenorrhea: It is highly effective for relieving primary dysmenorrhea, the clinical term for painful menstrual periods or cramps.⁴
• Pericarditis: In a hospital or specialist setting, higher prescription doses of ibuprofen are recommended by the American College of Cardiology for treating acute pericarditis, which is the inflammation of the membrane surrounding the heart.⁶

This wide array of applications gives rise to a crucial distinction in how ibuprofen is used: for acute, short-term relief versus for chronic, long-term management.

The public perception of ibuprofen is largely shaped by its over-the-counter availability and its role in treating temporary issues like a headache or a minor sprain.

This common experience fosters a sense of familiarity and safety.

However, this perception can obscure the very different reality of its use for chronic conditions like rheumatoid arthritis.

In these cases, the medicine must be taken regularly, often at higher prescription doses, for weeks, months, or even years to manage symptoms.¹⁰

This long-term exposure is precisely what elevates the risk of the serious cardiovascular, gastrointestinal, and renal side effects detailed later in this report.

Conflating the safety profile of taking ibuprofen for two days for a fever with taking it for two years for arthritis is a common but potentially dangerous misunderstanding.

Therefore, the clinical application of the drug directly dictates its risk profile for the individual patient.

IV. A Comprehensive Guide to Administration and Dosage

Safe and effective use of ibuprofen hinges on understanding its various formulations, the critical difference between over-the-counter (OTC) and prescription strengths, and adherence to appropriate dosage guidelines.

4.1 Available Formulations

Ibuprofen is manufactured in a variety of forms to accommodate different patient needs, ages, and clinical situations.⁷

• Oral Solids: The most common forms are tablets, capsules, and liquid-filled capsules (liquid gels).⁷
• Oral Liquids: Liquid suspensions are available for pediatric patients and for adults who have difficulty swallowing pills.⁷
• Topical Applications: For localized pain, such as in a specific joint or muscle, ibuprofen is available as a topical gel or cream. This allows the drug to be absorbed through the skin directly at the site of pain, which can minimize systemic side effects.⁷
• Other Forms: Less common formulations include suppositories for rectal administration and intravenous (IV) solutions (e.g., brand name Caldolor) for use in a hospital setting, typically for managing acute pain or fever when oral administration is not possible.⁷

4.2 Over-the-Counter (OTC) vs. Prescription Strength

A fundamental distinction exists between the ibuprofen available for purchase directly by consumers and that which requires a doctor’s prescription.⁶

• Over-the-Counter (OTC) Ibuprofen: Typically available in 200 mg doses, OTC ibuprofen is intended for the temporary relief of minor aches, pains, and fever. Its use should be short-term.
• Prescription Ibuprofen: Available in higher strengths (e.g., 400 mg, 600 mg, 800 mg), prescription ibuprofen is used to manage more severe pain or chronic inflammatory conditions like arthritis.⁶

This distinction is not arbitrary; it is a public health measure designed to ensure that higher doses and long-term use, which carry greater risks, occur under the supervision of a healthcare professional who can monitor for potential adverse effects.⁴

4.3 Dosage Guidelines

Dosage for ibuprofen is highly specific and depends on the patient’s age, weight (especially in children), the condition being treated, and the strength of the medication (OTC vs. prescription).

The instruction “as needed” is frequently found on packaging but can be dangerously subjective.

A person with chronic pain might feel they “need” the medication daily, inadvertently sliding from appropriate short-term use into high-risk long-term use without medical oversight.

Therefore, it is essential to adhere to concrete limits.

For unsupervised OTC use, a critical safety guardrail is not to take ibuprofen continuously for more than three days for a fever or ten days for pain without consulting a physician.⁷

This rule provides a clear, actionable boundary to the vague “as needed” directive.

The following table consolidates dosage information from clinical guidelines to provide a clearer picture of appropriate use.

Table 1: Ibuprofen Dosage Guidelines (Adult & Pediatric)

Indication	Patient Population	Typical Dosage	Maximum Daily Dose
Mild to Moderate Pain	Adults & Teenagers	200 mg to 400 mg orally every 4 to 6 hours, as needed 4	OTC: 1200 mg 6	Prescription: 3200 mg 6
Menstrual Cramps	Adults	400 mg orally every 4 hours, as needed 10	Consult physician for use beyond a few days.
Fever	Adults & Teenagers	200 mg to 400 mg orally every 4 to 6 hours, as needed 4	OTC: 1200 mg
Osteoarthritis & Rheumatoid Arthritis	Adults & Teenagers	Prescription Only: 1200 mg to 3200 mg per day, divided into 3 or 4 equal doses 10	3200 mg 6
Acute Pericarditis	Adults	Prescription Only: 600 mg to 800 mg orally every 8 hours 6	2400 mg
Pain or Fever	Children (6 months to 12 years)	Dose is based on body weight and must be determined by a doctor. Typically 5 mg/kg to 10 mg/kg per dose, every 6 to 8 hours.10	40 mg/kg 10

Note: For all pediatric use and for any use in infants younger than 6 months, a physician must determine the dose.

Dosages for specific patient populations, such as those with renal or hepatic impairment, may need to be adjusted and require medical supervision.⁶

V. The Risk Profile: A Critical Examination of Adverse Effects and Contraindications

Despite its widespread availability and effectiveness, ibuprofen carries a significant risk profile that necessitates careful and informed use.

The U.S. Food and Drug Administration (FDA) has mandated its most serious type of caution, a “black box warning,” for ibuprofen and other NSAIDs, highlighting potentially life-threatening risks.⁴

These risks are not rare and are directly linked to the drug’s mechanism of action, dose, and duration of use.

5.1 The FDA Black Box Warning: Cardiovascular and Cerebrovascular Risks

The primary FDA warning concerns the increased risk of serious cardiovascular events.⁴

• Heart Attack and Stroke: People who take NSAIDs like ibuprofen (other than aspirin) may have a higher risk of having a heart attack or a stroke than people who do not. These events can occur without warning and may be fatal.⁴
• Risk Factors: The risk is present for everyone but may be higher for individuals who take NSAIDs for a long time, use higher doses, or have pre-existing heart disease or risk factors for it. These risk factors include a personal or family history of heart disease, a previous heart attack or stroke, smoking, high blood pressure, high cholesterol, or diabetes.⁴
• Absolute Contraindications: Ibuprofen should not be taken if a person has recently had a heart attack, unless specifically directed by a doctor. Furthermore, its use is strictly contraindicated immediately before or after coronary artery bypass graft (CABG) surgery.⁴

5.2 Gastrointestinal (GI) Complications

The second part of the black box warning addresses severe gastrointestinal risks, which are a direct consequence of ibuprofen’s inhibition of protective prostaglandins in the stomach lining.⁴

• Ulcers, Bleeding, and Perforation: NSAIDs can cause ulcers, bleeding, or holes (perforations) in the esophagus, stomach, or intestine. These events can develop at any time during treatment, may occur without any warning symptoms, and can be fatal.⁴
• Risk Factors: The risk of GI complications is elevated in people who take NSAIDs for a long time, are of older age, have a history of stomach ulcers or bleeding, are in poor health, smoke, or consume large amounts of alcohol while taking the medication.⁴
• Common GI Side Effects: Beyond these severe risks, more common and less dangerous side effects include heartburn, indigestion, gas, bloating, nausea, vomiting, diarrhea, and constipation.⁷

5.3 Renal (Kidney) and Hepatic (Liver) Considerations

The kidneys are particularly vulnerable to the effects of NSAIDs because they rely on prostaglandins to maintain adequate blood flow.

• Kidney Damage: Long-term use of ibuprofen has been associated with kidney failure.⁹ It should be used with extreme caution or avoided in patients with pre-existing kidney disease or conditions that compromise renal blood flow, such as heart failure, cirrhosis, or dehydration.⁶
• Liver Damage: While rare, liver failure has been associated with ibuprofen use. Caution is advised for patients with pre-existing liver disease.⁶

5.4 Use in Specific Populations

Certain populations are at a heightened risk of adverse effects and must exercise particular caution.

• Pregnancy: The FDA has issued a specific warning against using NSAIDs, including ibuprofen, at or after 20 weeks of pregnancy. This is due to the risk of the drug causing fetal kidney problems, which can lead to low levels of amniotic fluid (oligohydramnios) and subsequent complications. Use after 30 weeks of pregnancy is strongly discouraged due to the risk of causing a premature closure of a vital fetal blood vessel, the ductus arteriosus.⁶ While safety in early pregnancy is unclear, it is generally considered harmful in later pregnancy.⁹
• Asthma: Ibuprofen can trigger or worsen asthma attacks in some susceptible individuals.⁹
• Other Pre-existing Conditions: Patients with bleeding disorders, Crohn’s disease, or ulcerative colitis should be cautious, as NSAIDs can exacerbate these conditions.⁷

5.5 Significant Drug Interactions

Combining ibuprofen with other medications can dramatically increase the risk of adverse events.

It is crucial to inform a healthcare provider of all medications being taken.

Key interactions include:

• Anticoagulants (‘Blood Thinners’): Taking ibuprofen with drugs like warfarin increases the risk of serious bleeding.⁴
• Aspirin and Other NSAIDs: Combining ibuprofen with aspirin or another NSAID (e.g., naproxen) does not increase efficacy but significantly multiplies the risk of GI and other side effects. This includes taking two different branded products that both contain an NSAID.⁴
• Oral Steroids: Use with corticosteroids like prednisone greatly increases the risk of stomach ulcers and bleeding.⁴
• SSRIs: Selective serotonin reuptake inhibitors, a class of antidepressants (e.g., citalopram, fluoxetine), can also increase the risk of bleeding when taken with ibuprofen.⁴

To consolidate this critical safety information, the following table summarizes the primary risks and associated warning signs that demand immediate medical attention.

Table 2: Ibuprofen Risk Profile Summary

Risk Category	Potential Complication	Key Warning Symptoms Requiring Immediate Medical Attention
Cardiovascular	Heart Attack, Stroke	Chest pain, shortness of breath, weakness in one part or side of the body, slurred speech 4
Gastrointestinal	Ulcers, Bleeding, Perforation	Stomach pain, severe heartburn, vomit that is bloody or looks like coffee grounds, blood in the stool, black and tarry stools 4
Renal (Kidney)	Acute Kidney Injury, Chronic Kidney Disease	Decreased urination, swelling in legs and feet, fatigue, shortness of breath.
Allergic Reaction	Anaphylaxis	Hives, facial swelling, wheezing, difficulty breathing, skin rash.

VI. The Global Footprint: Market Presence, Brand Diversity, and Historical Significance

Ibuprofen’s journey from a laboratory discovery to a global pharmaceutical staple is a story of scientific innovation and massive commercial success.

This trajectory has made it one of the most important and widely used medicines in modern history, but its ubiquity has also created unique public health challenges related to brand confusion and risk perception.

6.1 A Landmark Discovery

The development of ibuprofen was a direct response to a clinical need.

In the mid-20th century, the primary treatment for chronic inflammatory conditions like rheumatoid arthritis was corticosteroids.

While effective, these steroids carried a heavy burden of side effects.

Seeking a safer alternative, a research team at Boots UK Limited, led by Dr. Stewart Adams and Dr. John Nicholson, embarked on a years-long search.⁶

Their work culminated in the discovery of ibuprofen, which was patented in 1961.

It was first marketed under the brand name Brufen in the United Kingdom in 1969, followed by its introduction to the United States in 1974.⁹

6.2 A Global Staple

Ibuprofen’s efficacy, combined with a relatively manageable risk profile when used appropriately, led to its rapid adoption worldwide.

Its importance is formally recognized by its inclusion on the World Health Organization’s List of Essential Medicines, a curated list of the most effective and safe medications needed to meet the most important needs in a health system.⁹

The expiration of its patent allowed for the manufacturing of generic ibuprofen, which dramatically lowered its cost and increased its accessibility.⁹

This has cemented its status as a first-line treatment for pain, fever, and inflammation across the globe.

Its immense popularity is reflected in prescription statistics; in 2022, it was the 33rd most commonly prescribed medication in the United States, accounting for over 17 million prescriptions.⁹

This figure does not even capture the vast volume of ibuprofen sold over-the-counter, which is likely many times greater.

6.3 The Maze of Brand Names

This evolution from a targeted prescription drug for arthritis into a ubiquitous OTC commodity has led to its marketing under a staggering number of different brand names around the world.¹³

While this brand diversity reflects its commercial success, it also presents a significant and often underestimated risk to public health: accidental overdose due to brand confusion.

A consumer may not realize that multiple products marketed for different ailments contain the exact same active ingredient.

For example, a person might take Advil for a headache and Motrin for muscle pain, unknowingly consuming a double dose of ibuprofen and substantially increasing their risk of adverse effects.

This is particularly concerning with multi-symptom cold and flu remedies or menstrual products, which can combine ibuprofen with other active ingredients.

The brand Midol, for instance, has various formulations that may contain ibuprofen, naproxen, or acetaminophen, making it imperative for consumers to read the active ingredient list on any product they take.⁸

The following table lists some of the most common brand names for ibuprofen in various countries to help consumers identify the active ingredient regardless of the packaging.

Table 3: Common Global Brand Names of Ibuprofen

Brand Name	Common Countries/Regions
Advil	USA, Canada, Australia, Brazil, France, Mexico, South Africa 13
Motrin	USA, Canada, North Macedonia 13
Nurofen	UK, Australia, Germany, France, Italy, New Zealand, South Africa, Russia 13
Brufen	UK, India, Italy, Pakistan, New Zealand, South Africa, Egypt 13
Midol	USA (Note: Check label, as some products contain other painkillers) 8
Ibalgin	Czech Republic, Slovakia, Romania 13
Dalsy	Spain, Brazil, Croatia 13
Alivium	Brazil 13
Dolgit	Germany, Austria, Hungary, Turkey 13
Ipren	Denmark, Sweden 13
Note: This is a partial list. Ibuprofen is sold under hundreds of names globally. Always check the “Active Ingredients” section on the drug facts label.13

VII. The Scientific Frontier: Emerging Research and Future Potential

Even for a drug as well-established as ibuprofen, scientific inquiry continues to explore new potential applications and to refine our understanding of its effects.

This ongoing research demonstrates that even decades-old molecules can hold new promise, but it also serves as a constant reminder of the fundamental principle of risk-benefit analysis in medicine.

7.1 Potential Neuroprotective Effects

One of the most intriguing areas of recent research has been the investigation of ibuprofen’s potential role in neurodegenerative diseases, particularly Parkinson’s disease.

Multiple studies have suggested an association between regular NSAID use and a lower risk of developing Parkinson’s.

A notable 2011 study from researchers at Harvard Medical School reported that people who regularly consumed ibuprofen had a 38% lower risk of developing the disease compared to non-users.⁹

Interestingly, this neuroprotective effect appeared to be specific to ibuprofen; no similar effect was found for other common pain relievers like aspirin or paracetamol (acetaminophen).⁹

While this finding is scientifically tantalizing, it must be interpreted with extreme caution.

The researchers themselves highlighted that the known, serious risks of long-term ibuprofen use—particularly to the gastrointestinal and renal systems—make it entirely unsuitable as a preventative strategy for the general population.⁹

This situation perfectly illustrates the core dilemma of pharmacology: a potential benefit, no matter how promising, cannot be considered in isolation from a drug’s established harms.

The prospect of preventing a devastating disease like Parkinson’s cannot, with current evidence, justify exposing millions of healthy people to the significant risks of daily ibuprofen use.

It remains an active and important area of research, but not a basis for clinical recommendations.

7.2 Other Investigational Uses

Scientific curiosity has led to the exploration of ibuprofen for a variety of other conditions:

• Dermatology: Leveraging its anti-inflammatory properties, ibuprofen has been studied for the treatment of acne. In Japan, it has been sold in a topical formulation specifically for adult acne.⁹
• Orthostatic Hypotension: Some research suggests that NSAIDs, including ibuprofen, may be useful in managing severe orthostatic hypotension, a condition characterized by a sharp drop in blood pressure upon standing up.⁹
• Alzheimer’s Disease: Given the inflammatory component of Alzheimer’s disease, there has been considerable interest in whether NSAIDs could help prevent or treat it. However, at present, the evidence is unclear, and their utility for this purpose has not been established.⁹

These areas of research underscore that our understanding of even the most common drugs is continually evolving.

They also reinforce the central theme of this report: ibuprofen is a powerful and effective medication, but it is a tool that must be used with respect for its inherent risks.

Every potential new benefit must be rigorously weighed against its well-documented potential for harm, a calculation that lies at the very heart of responsible medicine.

Conclusion

Ibuprofen is a cornerstone of modern pharmacotherapy, a testament to a successful search for an effective nonsteroidal anti-inflammatory agent.

Its journey from a prescription-only arthritis treatment to a globally ubiquitous over-the-counter remedy for countless common ailments highlights its remarkable utility.

Its mechanism of action—the inhibition of prostaglandin synthesis—is the source of its threefold power as an analgesic, antipyretic, and anti-inflammatory drug.

However, this ubiquity belies a complex and serious risk profile.

The same mechanism that provides relief is also responsible for a well-documented risk of severe cardiovascular, gastrointestinal, and renal complications.

These risks, underscored by an FDA black box warning, are magnified by higher doses and, most critically, by the duration of use.

A crucial distinction must therefore be made between the appropriate, short-term use for acute conditions and the high-risk nature of unsupervised, long-term use.

Informed and safe use of ibuprofen requires a multi-faceted understanding.

It demands adherence to strict dosage and duration limits, a keen awareness of the warning signs of serious adverse effects, and vigilance against combining it with interacting medications.

Furthermore, in a crowded global marketplace, it requires consumers to look past brand names and identify the active ingredient to prevent accidental overdose.

The ongoing research into new applications for ibuprofen offers exciting possibilities but also serves as a potent reminder that in medicine, potential benefits must always be carefully weighed against known harms.

Ultimately, ibuprofen remains a highly valuable tool in managing pain and inflammation, but its power necessitates respect, caution, and educated, responsible use.

Works cited

1. www.cancer.gov, accessed on August 10, 2025, https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ibuprofen#:~:text=A%20drug%20used%20to%20treat,a%20substance%20that%20causes%20inflammation.
2. Definition of ibuprofen – NCI Dictionary of Cancer Terms, accessed on August 10, 2025, https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ibuprofen
3. Ibuprofen for adults: painkiller which also treats inflammation – NHS, accessed on August 10, 2025, https://www.nhs.uk/medicines/ibuprofen-for-adults/
4. Ibuprofen: MedlinePlus Drug Information, accessed on August 10, 2025, https://medlineplus.gov/druginfo/meds/a682159.html
5. IBUPROFEN Definition & Meaning – Dictionary.com, accessed on August 10, 2025, https://www.dictionary.com/browse/ibuprofen
6. Ibuprofen – StatPearls – NCBI Bookshelf, accessed on August 10, 2025, https://www.ncbi.nlm.nih.gov/books/NBK542299/
7. NSAIDs (Nonsteroidal Anti-Inflammatory Drugs): Uses – Cleveland Clinic, accessed on August 10, 2025, https://my.clevelandclinic.org/health/treatments/11086-non-steroidal-anti-inflammatory-medicines-nsaids
8. Acetaminophen vs. Ibuprofen: What to Take When – UnityPoint Health, accessed on August 10, 2025, https://www.unitypoint.org/news-and-articles/acetaminophen-vs-ibuprofen-what-to-take-when
9. Ibuprofen – Wikipedia, accessed on August 10, 2025, https://en.wikipedia.org/wiki/Ibuprofen
10. Ibuprofen (oral route) – Side effects & dosage – Mayo Clinic, accessed on August 10, 2025, https://www.mayoclinic.org/drugs-supplements/ibuprofen-oral-route/description/drg-20070602
11. Ibuprofen – Alcohol and Drug Foundation, accessed on August 10, 2025, https://adf.org.au/drug-facts/ibuprofen/
12. Ibuprofen: Brands & Uses – Cleveland Clinic, accessed on August 10, 2025, https://my.clevelandclinic.org/health/drugs/20168-ibuprofen-capsules-or-tablets
13. List of ibuprofen brand names – Wikipedia, accessed on August 10, 2025, https://en.wikipedia.org/wiki/List_of_ibuprofen_brand_names